Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetration
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetration
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 66, Issue 7, Pages 1573-1581
Publisher
Oxford University Press (OUP)
Online
2011-04-21
DOI
10.1093/jac/dkr151
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
- (2010) Steven A Yukl et al. AIDS
- Raltegravir Is a Substrate for SLC22A6: a Putative Mechanism for the Interaction between Raltegravir and Tenofovir
- (2010) Darren M. Moss et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Plasma and Intracellular (Peripheral Blood Mononuclear Cells) Pharmacokinetics of Once-Daily Raltegravir (800 Milligrams) in HIV-Infected Patients
- (2010) José Moltó et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intracellular and plasma steady-state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre-treated HIV-infected patients
- (2010) Rob Ter Heine et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society
- (2010) R. Mallone et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Pharmacokinetics of Multiple-Dose Darunavir in Combination with Low-Dose Ritonavir in Individuals with Mild-to-Moderate Hepatic Impairment
- (2010) Vanitha Sekar et al. CLINICAL PHARMACOKINETICS
- Evolution of Integrase Resistance During Failure of Integrase Inhibitor-Based Antiretroviral Therapy
- (2010) Hiroyu Hatano et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Implementation of Raltegravir in Routine Clinical Practice: Selection Criteria for Choosing This Drug, Virologic Response Rates, and Characteristics of Failures
- (2010) Alexandra U Scherrer et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Long-Term Efficacy and Safety of the HIV Integrase Inhibitor Raltegravir in Patients With Limited Treatment Options in a Phase II Study
- (2010) Jose M Gatell et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Effect of Low-, Moderate-, and High-Fat Meals on Raltegravir Pharmacokinetics
- (2010) Diana M. Brainard et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia
- (2009) Máirín Ryan et al. AIDS
- Assessment of the pharmacokinetics of co-administered maraviroc and raltegravir
- (2009) Emma Andrews et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Omeprazole on Plasma Levels of Raltegravir
- (2009) Marian Iwamoto et al. CLINICAL INFECTIOUS DISEASES
- Clinical Pharmacokinetics and Pharmacodynamics of Etravirine
- (2009) Monika Schöller-Gyüre et al. CLINICAL PHARMACOKINETICS
- Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action
- (2009) Caroline Bazzoli et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics of Raltegravir in Individuals With UGT1A1 Polymorphisms
- (2009) LA Wenning et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics and Safety of Etravirine Administered Once or Twice Daily After 2 Weeks Treatment With Efavirenz in Healthy Volunteers
- (2009) Marta Boffito et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A LC–tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine
- (2009) A. Fayet et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Optimal use of maraviroc in clinical practice
- (2008) Vincent Soriano et al. AIDS
- Minimal Pharmacokinetic Interaction between the Human Immunodeficiency Virus Nonnucleoside Reverse Transcriptase Inhibitor Etravirine and the Integrase Inhibitor Raltegravir in Healthy Subjects
- (2008) M. S. Anderson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection
- (2008) David A. Cooper et al. NEW ENGLAND JOURNAL OF MEDICINE
- Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection
- (2008) Roy T. Steigbigel et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now